Logo image of ARQ

ARQ INC (ARQ) Stock Fundamental Analysis

USA - NASDAQ:ARQ - US00770C1018 - Common Stock

6.99 USD
-0.01 (-0.14%)
Last: 10/21/2025, 8:00:00 PM
6.99 USD
0 (0%)
After Hours: 10/21/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, ARQ scores 3 out of 10 in our fundamental rating. ARQ was compared to 83 industry peers in the Chemicals industry. ARQ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ARQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ARQ has reported negative net income.
ARQ had a positive operating cash flow in the past year.
In the past 5 years ARQ reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ARQ reported negative operating cash flow in multiple years.
ARQ Yearly Net Income VS EBIT VS OCF VS FCFARQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ARQ has a Return On Assets of -0.58%. This is in the lower half of the industry: ARQ underperforms 61.45% of its industry peers.
The Return On Equity of ARQ (-0.76%) is comparable to the rest of the industry.
The Return On Invested Capital of ARQ (0.53%) is worse than 80.72% of its industry peers.
Industry RankSector Rank
ROA -0.58%
ROE -0.76%
ROIC 0.53%
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ARQ Yearly ROA, ROE, ROICARQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

With a Operating Margin value of 1.47%, ARQ is not doing good in the industry: 75.90% of the companies in the same industry are doing better.
With a decent Gross Margin value of 36.27%, ARQ is doing good in the industry, outperforming 74.70% of the companies in the same industry.
ARQ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.47%
PM (TTM) N/A
GM 36.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
ARQ Yearly Profit, Operating, Gross MarginsARQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARQ is destroying value.
The number of shares outstanding for ARQ has been increased compared to 1 year ago.
ARQ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ARQ has an improved debt to assets ratio.
ARQ Yearly Shares OutstandingARQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ARQ Yearly Total Debt VS Total AssetsARQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ARQ has an Altman-Z score of 3.41. This indicates that ARQ is financially healthy and has little risk of bankruptcy at the moment.
ARQ's Altman-Z score of 3.41 is amongst the best of the industry. ARQ outperforms 80.72% of its industry peers.
ARQ has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
ARQ has a Debt to Equity ratio of 0.13. This is amongst the best in the industry. ARQ outperforms 86.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 3.41
ROIC/WACC0.06
WACC8.55%
ARQ Yearly LT Debt VS Equity VS FCFARQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

ARQ has a Current Ratio of 1.10. This is a normal value and indicates that ARQ is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.10, ARQ is not doing good in the industry: 90.36% of the companies in the same industry are doing better.
A Quick Ratio of 0.65 indicates that ARQ may have some problems paying its short term obligations.
ARQ has a Quick ratio of 0.65. This is amonst the worse of the industry: ARQ underperforms 89.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.65
ARQ Yearly Current Assets VS Current LiabilitesARQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

ARQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.67%, which is quite impressive.
The Revenue has grown by 11.96% in the past year. This is quite good.
ARQ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.22% yearly.
EPS 1Y (TTM)91.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%12.51%

3.2 Future

ARQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.64% yearly.
ARQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.79% yearly.
EPS Next Y95.41%
EPS Next 2Y109.09%
EPS Next 3Y88.93%
EPS Next 5Y63.64%
Revenue Next Year10.84%
Revenue Next 2Y16.73%
Revenue Next 3Y16.47%
Revenue Next 5Y17.79%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARQ Yearly Revenue VS EstimatesARQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
ARQ Yearly EPS VS EstimatesARQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

ARQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ARQ is valuated quite expensively with a Price/Forward Earnings ratio of 26.79.
Based on the Price/Forward Earnings ratio, ARQ is valued a bit more expensive than the industry average as 61.45% of the companies are valued more cheaply.
ARQ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.23.
Industry RankSector Rank
PE N/A
Fwd PE 26.79
ARQ Price Earnings VS Forward Price EarningsARQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

ARQ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ARQ is more expensive than 79.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.97
ARQ Per share dataARQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

ARQ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARQ's earnings are expected to grow with 88.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y109.09%
EPS Next 3Y88.93%

0

5. Dividend

5.1 Amount

ARQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARQ INC

NASDAQ:ARQ (10/21/2025, 8:00:00 PM)

After market: 6.99 0 (0%)

6.99

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners33.21%
Inst Owner ChangeN/A
Ins Owners18.57%
Ins Owner Change8.31%
Market Cap298.40M
Analysts82.22
Price Target10.91 (56.08%)
Short Float %4.68%
Short Ratio4.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.8%
Min EPS beat(2)-90.4%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)30.69%
Min EPS beat(4)-90.4%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)42.17%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.27%
Min Revenue beat(2)2.71%
Max Revenue beat(2)9.82%
Revenue beat(4)3
Avg Revenue beat(4)4.67%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)13.26%
Revenue beat(8)6
Avg Revenue beat(8)6.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.54%
EPS NY rev (1m)-118.18%
EPS NY rev (3m)-110.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.79
P/S 2.54
P/FCF N/A
P/OCF 39.13
P/B 1.38
P/tB 1.43
EV/EBITDA 25.97
EPS(TTM)-0.01
EYN/A
EPS(NY)0.26
Fwd EY3.73%
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)0.18
OCFY2.56%
SpS2.76
BVpS5.08
TBVpS4.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -0.76%
ROCE 0.73%
ROIC 0.53%
ROICexc 0.55%
ROICexgc 0.56%
OM 1.47%
PM (TTM) N/A
GM 36.27%
FCFM N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 629.02%
Cap/Sales 52.86%
Interest Coverage 250
Cash Conversion 65.64%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.65
Altman-Z 3.41
F-Score4
WACC8.55%
ROIC/WACC0.06
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y95.41%
EPS Next 2Y109.09%
EPS Next 3Y88.93%
EPS Next 5Y63.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%12.51%
Revenue Next Year10.84%
Revenue Next 2Y16.73%
Revenue Next 3Y16.47%
Revenue Next 5Y17.79%
EBIT growth 1Y145.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year777.58%
EBIT Next 3Y180.36%
EBIT Next 5Y107.02%
FCF growth 1Y-16.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.31%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%